Advancement in mRNA Therapeutics and Vaccines: Overcoming RNase-Related Challenges through RNase-free Single-Use Assemblies & Non-Thermal Plasma-based Inhibition
Time: 1:00 pm
day: Day Two
Details:
- Pioneering Non-Thermal Plasma inhibition of RNases as a cutting-edge alternative for ensuring RNase-free single-use bioprocess containers and assemblies, when conventional methods like thermal, irradiation and chemical inactivation fail
- Elevate mRNA development and manufacturing processes by mitigating the risk of RNase contamination
- Exploring the inhibition of RNase through ionized air targeted at enzymes, showcasing an innovative approach to safeguarding bioprocess integrity
